Carbonic anhydrases - A overview

Current Pharmaceutical Design

Volumn 14, Issue 7, 2008, Pages 603-614

  Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIGLAUCOMA AGENT; ANTIINFECTIVE AGENT; ANTIOBESITY AGENT; BENDROFLUMETHIAZIDE; BICARBONATE; CARBON DIOXIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; DICLOFENAMIDE; DIURETIC AGENT; DORZOLAMIDE; ETHOXZOLAMIDE; GLUCOSE; HISTIDINE; HYDROCHLOROTHIAZIDE; HYDROFLUMETHIAZIDE; HYDROXIDE; ISOENZYME; METHAZOLAMIDE; POLYTHIAZIDE; SULFAMIDE DERIVATIVE; SULFONAMIDE; TRICHLORMETHIAZIDE; UNINDEXED DRUG; UREA; WATER; ZINC ION; ANTINEOPLASTIC AGENT;

ARCHAEBACTERIUM; BACTERIUM; BIOMEDICINE; CANDIDA ALBICANS; CARBON DIOXIDE FIXATION; DIATOM; DRUG DESIGN; DRUG STRUCTURE; ELECTROLYTE TRANSPORT; ENZYME INHIBITION; ENZYME ISOLATION; ENZYME MECHANISM; EPILEPSY; GLAUCOMA; GLUCONEOGENESIS; HELICOBACTER PYLORI; HOMEOSTASIS; HUMAN; HYDRATION; HYDROLYSIS; MAMMAL; MULTIGENE FAMILY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PH; PHYLOGENETIC TREE; PLANT CELL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; TRANSPORT KINETICS; UREA CYCLE; X RAY CRYSTALLOGRAPHY; ANIMAL; CHEMISTRY; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; ANTI-OBESITY AGENTS; ANTINEOPLASTIC AGENTS; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 42149137302     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783877884     Document Type: Review

References (60)

1. Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7: 168-181.
2. Supuran CT, Scozzafava, A., Conway, J. (Eds.): Carbonic anhydrase - Its inhibitors and activators, CRC Press, Boca Raton (FL), USA, 2004, pp. 1-363, and reference cited therein.
3. Supuran CT, Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors Med Res Rev 2003; 23: 146-69.
4. Smith KS, Ferry JG. Prokaryotic carbonic anhydrases. FEMS Miscrobiol Rev 2000; 24: 335-66.
5. Badger MR, Price GD. The role of carbonic anhydrase in photosynthesis. Annu Rev Plant Physiol Plant Mol Biol 1994; 45: 369-92.
6. Thiry A, Dogné JM, Masereel B, Supuran CT. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. trends Pharmacol Sci 2006; 27:566-73.
7. Lane TW, Morel FM. A biological function for cadmium in marine diatoms. Proc Natl Acad Sci USA 2000; 97: 4627-31.
8. Hilvo M. Tolvanen M. Clark A. Shen B. Shah Waheed A, et al. Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem J 2005; 392: 93-92.
9. Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and suifamate inhibitors. J Med Chem 2005; 48: 7860-6
10. Nishimori I, Minakuchi T, Onishi S, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. DNA cloning, characterization and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. J Med Chem 2007; 50: 381-8
11. Vullo D, Voipio J, Innocenti A, Rivera C, Ranki H, Scozzafava A, et al. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett 2005: 15: 971-6
12. Whittington DA, Waheed A, Ulmasov B, Shah GN, Grubb JH, Sly WS, et al. Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein over-expressed in certain cancer tumor cell. Proc Natl Acad Sci USA 2001; 98: 9595-50
13. Lehtonen J, Shen B, Vihinen M, Casini A, Scozzafava A, Supuran CT, et al. Characterization of CA XIII, a novel member of the carbonic andhydrase isozyme family. J Biol Chem 2004; 279: 2719-27.
14. Whittington DA, Grubb JH, Waheed A, Shah GN, Sly WS, Christianson DW. Expression, assay, and structure of the extracellular domain of murine carbonic anhydrase XIV: Implications for selective inhibition of membrane-associated isozyme. J Biol Chem 2004; 279: 7223-8.
15. Briganti F, Mangani S, Orioli P, Scozzafava A, Vernaglione G, Supuran CT. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry 1997; 36: 10384-92.
16. Stams T, Christianson DW. X-ray crystallographic studies of mammalian carbonic anhydrase isozymes. In The Carbonic Anhydrases - New Horizons; Chegwidden W.R., Edwards, Y., Carter, N. Eds.; Birkhäuser Verlag; 2000, Basel, pp. 159-74.
17. Casini A, Antel J, Abbate P, Scozzafava A, David S, Waldeck H, et al. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II, and IV. Bioorg Med Chem Lett 2003; 13: 841-5.
18. De Simone G, Di Fiore A, Menchise V, Pedone C, Antel J, Casini A, et al. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. Bioorg Med Chem Lett 2005; 15: 2315-20.
19. Menchise V, De Simone G, Alterio V, Di Fiore A, Pedone C, Scozzafava A, et al. Carbonic anhydrase inhibitors: Stacking with Phe131 determines active site buiding region of inhibitors as exemplified by the X-ray crystal structure of membrane-impermeant antitumor sulfonamide complexed with isozyme II. J Med Chem 2005; 48: 5721-7.
20. Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, et al. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX. J Am Chem Soc 2006; 128: 8329-35.
21. Abbate F, Winum JY, Potter BV, Casini A, Montero JL, Scozzafava A, et al. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase. Bioorg Med Chem Lett 2004; 14: 231-4.
22. Winum JY, Temperini C, El Cheikh K, Innocenti A, Vullo D, Ciattini S, et al. Carbonic anhydrase inhibitors: Clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozymic II, exemplified by the crystal structure of the topiramate sulfamide analogue. J Med Chem 2006; 49: 7024-31.
23. Supuran CT, Casini A, Scozzafava A. Development of sulfonamide carbonic anhydrase inhibitors. In Carbonic anhydrase - Its inhibitors and activators, Supuran, C.T., Scozzafava, A., Conway, J. (Eds); CRC Press, Boca Raton (FL), USA, 2004, pp. 67-148
24. Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004; 19: 199-229.
25. Di Fiore A, Pedone C, D'Ambrosio K, Scozzafava A, De Simone G, Supuran CT: Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. Bioorg Med Chem Lett 2006; 16: 437-42.
26. Scozzafava A, Briganti F, Ilies MA, Supuran CT: Carbonic anhydrase inhibitors: Synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J Med Chem 2000; 43: 292-300.
27. Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT: Carbonic anhydrase inPibitors: perfluoroalkyl/arylsubstituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged durantion of action. J Med Chem 2000; 43: 4542-51.
28. Abbate F, Casini A, Owa T, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg Med Chem Lett 2004; 14: 217-23.
29. Abbate F, Coetzee A, Casini A, Ciattini S, Scozzafava A, Supuran CT: Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride. Bioorg Med Chem Leo, 2004; 14: 337-41.
30. Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, et al. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: New pharmacological opportunities due to related binding site recognition. J Med Chem 2004; 47: 550-7.
31. Cecchi A, Hulikova A, Pastorek J, Pastorekova S, Scozzafava A, Winum JY, et al. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J Med Chem 2005; 48: 4834-41.
32. Svastova E, Hulikova A, Rafajova M, Zat'ovicova M, Gibadulinova A, Casini A, et al. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 2004: 577: 439-45.
33. Köhler K, Hillebrecht A, Schulze Wischeler J, Innocenti A, Heine A, Supuran CT, et al. Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste. Angew Chem Int Ed Engl 2007; 46: 7697-9
34. Temperini C, Innocenti A, Mastrolorenzo A, Scozzafava A, Supuran CT. Carbonic anhydranse inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: Kinetic and X-ray crystallographic studies. Bioorg Med Chem Lett 2007; 17: 4866-72.
35. Cronk JD, Endrizzi JA, Cronk MR, O'Neill JW, Zhang KYJ. Crystal structure of E. coli β-carbonic anhydrase, an enzyme with an unusual pH-dependent activity. Protein Sci 2001; 10: 911-922.
36. Kimber MS, Pai EF. The active site architecture of Pisum sativum β-carbonic anhydrase is a mirror image of that of α-carbonic anhydrases. EMBO J 2000; 19: 2323-2330.
37. 2 hydration. J Biol Chem 2000; 275: 5521-6.
38. Smith KS, Ferry JG. A plant-type (β-class) carbonic anhydrase in the thermophilic methanoarchaeon Methanobacterium thermoautotrophicum. J Bacteriol 1999; 181: 6247-53.
39. Strop P, Smith KS, Iverson TM, Ferry JG, Rees DC. Crystal structure of the "cab"-type beta class carbonic anhydrase from the archaeon Methanobacterium thermoautotrophicum. J Biol Chem 2001; 276: 10299-305.
40. Zimmerman, S.; Innocenti, A.; Casini, A.; Ferry, J.G.; Scozzafava, A.; Supuran, C.T. Carbonic anhydrase inhibitors. Inhibition of the prokaryotic beta and gamma-class enzymes from Archaea with sulfonamides. Bioorg Med Chem Lett 2004; 14: 6001-6.
41. 2 sensing with cAMP signaling and virulence. Curr Biol 2005; 15: 2021-6.
42. Nishimori I, Minakuchi T, Kohsaki T, Onishi S, Takeuchi H, Vullo D, et al. Carbonic anhydrase inhibitors: The beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. Bioorg Med Chem Lett 2007;17: 3585-94.
43. Kisker C, Schindelin H, Alber BE, Ferry JG, Rees DC. A left-hand beta-helix revealed by the crystal structure of a carbonic anhydrases from the archaeon Methanosarcina thermophila. EMBO J 1996; 15: 2323-30.
44. Iverson TM, Alber BE, Kisker C, Ferry JG Rees DC. A closer look at the active site of gamma-class carbonic anhydrases: High-resolution crystallograpluc studies of the carbonic anhydrase from Methanosarcina thermophila. Biochemistry 2000; 39: 9222-31.
45. Innocenti A, Zimmerman S, Casini A, Ferry JG, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of the zinc and cobalt gamma-class enzyme from the archaeon Methanosarcina thermophila with anions Bioorg Med Chem Lett 2004; 14: 3327-31.
46. Cox EH, McLendon GL, Morel FM, Lane TW, Prince RC, Pickering IJ, et al. The active site structure of Thalassiosira weissflogii carbonic anhydrase 1. Biochemistry 2000; 39: 12128-30.
47. Nishimori I, Minakuchi T, Morimoto K, Sano S, Onishi S, Takeuchi H, et al. Carbonic adhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem 2006; 49: 2117-26.
48. Nishimori I, Vullo D, Minakuchi T, Morimoto K, Onishi S, Scozzafava A, et al. Carbonic anhydrase inhibitors: Cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacler pylori. Bioorg Med Chem Lett 2006; 16: 2182-8.
49. Krungkrai j, Scozzafava A, Reungprapavut S, Krungkrai SR, Rattanajak R, Kamchonwongpaisan S, et al. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anbydrase with aromatic sulfonamides: Towards antimalarials with a novel mechanism of action? Bioorg Med Chem 2005; 13: 483-9.
50. Park Y, Karlsson J, Rojdestvenski I, Pronina N, Klimov V, Oquist G, et al. Role of a novel photosystem II - associated carbonic anhydrase in photosynthetic carbon assimilation in Chlamydomonas reinhardtii. FEBS Lett 1999; 444: 102-5.
51. Parkkila S. An overview of the distribution and function of carbonic anhydrase in mammals. In The Carbonic Anhydrases - New Horizons, Chegwidden W.R., Edwards, Y., Carter, N. Eds.; Birkhäuser Verlag, Basel, 2000, pp. 79-93.
52. Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavsky R, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994; 9: 2877-88.
53. Clare BW, Supuran CT. Carbonic anhydrase activators. Part 3. Structure-activity correlations for a series of isozyme II activators. J Pharm Sci 1994; 83: 768-79.
54. Temperini C, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV. Bioorg Med Chem Lett 2007;17: 628-35
55. Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isozymess I, II, IV, VA, VII, and XIV with L- and D-histidine and crystallographic analysis of their adducts with isoform II: Engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006; 12: 7057-66.
56. Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: Stereospecific recognition within the active site of an enzyme and its consequences for the drug design. J Med Chem 2006; 49: 3019-27,
57. Scozzalava A, Supuran CT. Carbonic abhydrase activators: Human isozyme II is strongly activated by oligopeptides incorporating the carboxyterminal sequence of the bicarbonate anion exchanger AE1. Bioorg Med Chem Lett 2002, 12, 1177-80.
58. Supuran CT, Scozzafava A. Activation of carbonic anhydrase isozymes. In The Carbonic Anhydrases - New Horizons; Chegwidden W. R., Carter, N., Edwards, Y., Eds.; Birkhauser Verlag: Basel, Switzerland, 2000: 197-219
59. Ilies M, Scozzafava A, Supuran CT. Carbonic anhydrase activators. In Carbonic anhydrase - Its inhibitors and activators; Supuran, C. T., Scozzafava, A., Conway, J., Eds., CRC Press: Boca Raton, FL, 2004: 317-52.
60. Supuran CT, Scozzafava A. Carbonic anhydrase activators as potential anti-Alzheimer's disease agents. In Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies; Smith, H. J., Simons, C., Sewell, R. D. E., Eds.; CRC Press: Boca Raton, FL, 2008, pp. 265-88